Close Menu
Home » Twist Bioscience Fiscal Q4 Revenues Increase 87 Percent

Twist Bioscience Fiscal Q4 Revenues Increase 87 Percent

Dec 11, 2019
|
staff reporter

NEW YORK – Twist Bioscience reported after the close of the market on Wednesday that revenues for its fiscal fourth quarter 2019 rose 87 percent year over year.

For the three months ended Sept. 30, 2019, the firm reported revenues of $15.7 million compared to $8.4 million in the year-ago period. It beat analysts' average revenue estimate of $14.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Cost of a Visa

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

Rethinking Access Order

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

May Have to Close

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

Nature Papers Present Way to Analyze Cancer Mutational Signatures, Explore Treatment Resistance in Lung Cancer, More

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.

What's Popular?

In Business News

  1. Illumina Seeks Preliminary Injunction Against BGI in US Patent Infringement Case

  2. Invitae Q4 2019 Revenues Increase 47 Percent

  3. 10x Genomics Previews New Product Lineup Ahead of AGBT

    Premium

  4. 10x Genomics Q4 Revenues Grow 49 Percent

  5. Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics for Late-Stage Liver Disease

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.